Response to Letters Regarding Article, "Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis"
Circulation
.
2016 Mar 22;133(12):e450-1.
doi: 10.1161/CIRCULATIONAHA.116.021162.
Authors
Marianna Fontana
1
,
Silvia Pica
1
,
Patricia Reant
1
,
Amna Abdel-Gadir
1
,
Thomas A Treibel
1
,
Sanjay M Banypersad
1
,
Viviana Maestrini
1
,
William Barcella
1
,
Stefania Rosmini
1
,
Heerajnarain Bulluck
1
,
Rabya H Sayed
2
,
Ketna Patel
2
,
Shameem Mamhood
2
,
Chiara Bucciarelli-Ducci
3
,
Carol J Whelan
2
,
Anna S Herrey
1
,
Helen J Lachmann
2
,
Ashutosh D Wechalekar
2
,
Charlotte H Manisty
1
,
Eric B Schelbert
4
,
Peter Kellman
5
,
Julian D Gillmore
2
,
Philip N Hawkins
2
,
James C Moon
1
Affiliations
1
The Heart Hospital, London, United Kingdom.
2
National Amyloidosis Centre, University College London, Royal Free Hospital, London, United Kingdom.
3
Bristol Heart Institute, University of Bristol, Bristol, United Kingdom.
4
University of Pittsburgh School of Medicine, Pittsburgh, PA.
5
National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD.
PMID:
27002091
PMCID:
PMC4806551
DOI:
10.1161/CIRCULATIONAHA.116.021162
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Amyloidosis / diagnosis*
Cardiomyopathies / diagnosis*
Female
Humans
Magnetic Resonance Imaging / methods*
Male
Myocardium / pathology*
Grants and funding
FS/12/ 56/29723/BHF_/British Heart Foundation/United Kingdom
FS/12/56/29723/BHF_/British Heart Foundation/United Kingdom
Z99 HL999999/ImNIH/Intramural NIH HHS/United States
FS/10/40/28260/BHF_/British Heart Foundation/United Kingdom
DRF-2013-06-102/DH_/Department of Health/United Kingdom